Introduction {#S0001}
============

Cadmium (Cd) is one of the most prevalent environmental and biologically hazardous toxicants among metals. With no any reported significance in the biological system; it has been documented as a major pollutant in environment and biological systems \[[@CIT0001], [@CIT0002]\]. It gets into our body through occupational exposure by inhaling fine dust and fume in industries of cement, petroleum, fertilizers, mining, steel and iron and even at the hospital and municipal solid waste incineration plants \[[@CIT0003]\]. It is also used as a food adulterant to increase the look, flavor and shelf life of many food items and beverages like soft drinks, fruit juice, bread, root crops, and vegetables. It is also found in cigarette smoke, rechargeable batteries and certain types of cosmetics. The presence of Cd over the permissible level has acute as well as chronic health hazards. It can cause various clinical problems including upper respiratory tract irritation, pulmonary edema, muscular dystrophy, osteoporosis, neurological disorders and even cancers depending on the dose and incubation \[[@CIT0004]--[@CIT0006]\]. So, with its prevalence in daily, general consuming products, a great deal of scientific research is focused on ameliorating the toxic of Cd around the world.

Zinc (Zn) is one of the most important transition metals after iron in all forms of the biological system. It is supposedly imparted in over 100 enzymes assisting in metabolism, DNA-transcription, stress management, immunity, reproduction and nervous system \[[@CIT0007]\]. It can act as a nutrient and antioxidant if taken in moderation while it acts as a pro-oxidant and even toxicant if taken in high dose \[[@CIT0008]\]. It is required for the expression of important antioxidant molecules like superoxide dismutase and metallothionein that maintains redox homeostasis in living organisms \[[@CIT0009], [@CIT0010]\]. Besides, its excess as well as deficiency both have negative effects on the immune response exacerbating any infection or inflammation in animals and humans \[[@CIT0007], [@CIT0011]\].

No doubt that chemokines are involved in a wide variety of processes during pathological conditions \[[@CIT0012]\] by directing the migration and positioning of inflammatory and immune cells within the tissue \[[@CIT0013]\]. They can be secreted by and act on different cell types depending on the expression of specific receptors, and are known to be involved in leukocyte trafficking \[[@CIT0014]\]. Recruited Th1 lymphocytes may enhance interferon γ (IFN-γ) and tumor necrosis factor α (TNF-α) production, which in turn stimulates CXCL10 secretion from a variety of cells \[[@CIT0015]\]. CXCL10 is secreted by several cell types including CD4+, CD8+, NK and NK-T cells, endothelial cells, fibroblasts, keratinocytes, thyrocytes, preadipocytes, etc. \[[@CIT0015]\]. Th2 lymphocytes expressing CCR4 are attracted by CCL22, while Th17 lymphocytes expressing CXCR3 and CCR6 are attracted to the liver by the secretion of CXCL9, CXCL10 and CXCL11 \[[@CIT0013]\]. Recent studies have targeted the interaction between CCR4 expressed on Tregs and its ligands, CCL22, (macro-phage-derived chemokine) and CCL17 (actiwation-regulated chemokine), to inhibit transiently the recruitment of Tregs at the site of immunization \[[@CIT0016]\].

The present study is aimed to address the toxicological threats posed by Cd with the help of supplementation of Zn in a rodent-based investigation.

Material and methods {#S0002}
====================

Chemicals {#S20003}
---------

Cadmium as Cadmium chloride (CdCl~2~) and Zinc as Zinc chloride (ZnCl~2~) were purchased from Merck (Darmstadt, Germany). All of the chemicals used in the present study were of the analytical purity.

Experimental animals {#S20004}
--------------------

A total of 40 male rats (12-week-old), weighing 120-150 g each, were purchased from the Central Animal House of the Faculty of Pharmacy at King Saud University, Riyadh, KSA. All the animals were acclimatized in metal cages inside a well-ventilated room for 2 weeks prior to the treatment. They were maintained under standard laboratory conditions (temperature 23°C, relative humidity 60-70% and a 12-h light/dark cycle) and were fed a diet of standard commercial pellets and water *ad libitum*.

Experimental design {#S20005}
-------------------

Animals were randomly distributed into four experimental groups (n = 10/group): group I served as the control group supplemented with 0.1 ml of saline. Group II was administered Cd at a dose of 2.2 mg/kg CdCl~2~ in 0.1 ml of saline by subcutaneous injection four times weekly for 2 months. Rats of group III were injected with Cd in the same way as group II followed by supplementation with Zn (2.2 mg/kg ZnCl~2~, injected subcutaneously four times weekly for 2 months) at the gap of one hour. Group IV was supplemented with Zn at a dose of 2.2 mg/kg ZnCl~2~ injected subcutaneously four times weekly for 2 months.

Assay of antioxidant enzymes (SOD and CAT) {#S20006}
------------------------------------------

The activity of different antioxidant enzymes were assayed with standard protocols. CuZn superoxide dismutase (CuZnSOD) was assayed by autoxidation of pyrogallol \[[@CIT0017]\] while that of catalase (CAT) was done by decomposition of hydrogen peroxide \[[@CIT0018]\].

Estimation of the glutathione level {#S20007}
-----------------------------------

The level of reduced glutathione (GSH) was estimated by the method of Jollow *et al*. \[[@CIT0019]\].

Estimation of the malondialdehyde level {#S20008}
---------------------------------------

The extent of lipid peroxidation was estimated by the method of Buege and Aust \[[@CIT0020]\] involving the measurement of total malondialdehyde (MDA).

Histological sections {#S20009}
---------------------

Spleen parts were collected from the sacrificed control and different treated groups of rats. Tissues were fixed in Bouin\'s fixative, processed in paraffin followed by their sectioning of 4 µm thickness. Moreover, sections were stained with Haematoxylin and Eosin (H&E) for general histological architecture. In each group, many sections from different rats were investigated to distinguish the clear and common changes that were finally photographed. Sections from at least five rats were carefully investigated.

Immunohistochemical detection of T and B cells {#S20010}
----------------------------------------------

Spleen samples were fixed in 10% neutral buffered formalin. Paraffin sections were cleared in xylene, rehydrated in graded ethanol (100-70%), immersed in water for 5 to 10 minutes, and incubated in 0.3% H~2~O~2~ in 70% methanol for 20 minutes to inhibit endogenous peroxidase activity. The specimens were then rinsed three times for 5 minutes in PBS, and epitopes were unmasked by boiling in citrate buffer (pH 6.0) for 15 minutes whenever necessary. The sections were then blocked for 60 minutes in 3% BSA, in 1% normal goat serum and 3% non-fat milk. Sections were incubated with primary antibodies anti-CD3 (pan T cells or anti-CD20; pan B cells) in 0.1% BSA overnight at 4°C in a humidified chamber. Samples were then rinsed in PBS and incubated with biotinylated secondary antibody in 0.1% BSA for 1 hour at room temperature, followed by avidin biotin amplification (ABC Elite) for 30 minutes. Sections were developed with 3,3-diaminobenzidine peroxidase substrate (Sigma). Sections were counterstained with Mayer haematoxylin for 3 minutes and mounted. Negative controls were set by substituting the primary antibody with PBS \[[@CIT0021]\]. Photographs of the sections were taken; the images were digitized using Adobe Photoshop (Adobe Systems, Mountain View, CA). The PCNA (the number of brown stained cells), anti-CD3 or anti-CD20-stained cells were determined at 20 random locations within the spleen follicles and the PALS for each animal from each group using a Leica Qwin 500 image analyzer.

RNA extraction and RT-PCR {#S20011}
-------------------------

RNA was extracted from the collected samples (RNA latter) using RNeasy Mini Kit (QIAGEN) according to the manufacturer\'s instructions. RT-PCR was performed using QIAGEN One Step RT-PCR kit as directed by the manufacturer\'s instruction manual. The desired genes were amplified using specific primers (e-oligos, Hawthorne, USA) listed in [Table 1](#T0001){ref-type="table"}. For each sample, 25 µl reaction mixture was performed. PCR reaction was carried out using Gene-Amp 9700 thermal cycler. RT-PCR products were analysed in 1.2% agarose gel. PCR conditions were optimized to allow semiquantitative comparisons of results, as previously described \[[@CIT0022]\]. The levels of the three mRNA and β-actin mRNA were quantified by gel electrophoresis and densitometry. mRNA levels were normalized versus β-actin and are expressed in arbitrary units.

###### 

List of primers used to amplify the desired genes

  Primer name                                                   Primer length
  ------------- ----------------------- ----------------------- ---------------
  CD68          Forward                 GGACCCACAACTGTCACTCAT   21
  Reverse       AAGCCCCACTTTAGCTTTACC   21                      
  Ccl-22        Forward                 AGGTCCCTATGGTGCCAATGT   21
  Reverse       CGGCAGGATTTTGAGGTCCA    20                      
  CXCL-10       Forward                 CCAAGTGCTGCCGTCATTTTC   21
  Reverse       GGCTCGCAGGGATGATTTCAA   21                      

Lymphocyte isolation {#S20012}
--------------------

Rats were anesthetized and euthanized; spleen was taken out immediately followed by their rinsing with cold phosphate buffered saline. Then, it was placed on a 200-mesh stain steel sieve and grounded with plunger of the glass syringe. Two volumes of isolated lymphocyte separation medium were added, mixed gently and centrifuged at 2,000 × g for 10 min. The top layer was discharged leaving the middle lamella layer showing color of milk cream containing lymphocytes. Five volumes of PBS buffer were added and centrifuged at 1,000 × g for 5 min. Precipitated lymphocytes were re-suspended in RPMI-1640 medium (making the final concentration of 1 × 10^6^ cells/ml). The viability of lymphocytes was analyzed using trypan blue, and in all acceptable preparations, it exceeded 95%.

Statistical analysis {#S20013}
--------------------

All the data have been expressed as mean ± standard error of mean (SEM) for 6 different preparations in duplicate. Their statistical significance was evaluated by oneway ANOVA and Tukey\'s *post hoc* analysis by \'GraphPad Prism 5\'. The probability of occurrence was selected at *p* ≤ 0.05. The treatment and the experiments were repeated twice to check reproducibility of the results.

Results {#S0014}
=======

Effect on the level of reduced glutathione {#S20015}
------------------------------------------

Glutathione (GSH) is considered as one of the main indicators of oxidative stress in the biological system. So, its estimation was conducted in tissue homogenates of spleen to assess the burden of oxidative stress after their treatment with Zn, Cd and their combination. The treatment of rats with Zn caused a decrease in its level by 8.4% in spleen samples while it was 40.4% in Cd-treated group spleen samples. Hitherto, a combination group with Cd and Zn treatment showed a healing effect of Zn on Cd-pre-treated rats demonstrating replenishment in the GSH level by 27.4% in spleen ([Fig. 1A](#F0001){ref-type="fig"}).

Glutathione (GSH) is considered as one of the main indicators of oxidative stress in the biological system. So, its estimation was conducted in tissue homogenates of spleen to assess the burden of oxidative stress after their treatment with Zn, Cd and their combination. The treatment of rats with Zn caused a decrease in its level by 8.4% in spleen samples while it was 40.4% in Cd-treated group spleen samples. Hitherto, a combination group with Cd and Zn treatment showed a healing effect of Zn on Cd-pre-treat-ed rats demonstrating replenishment in the GSH level by 27.4% in spleen ([Fig. 1A](#F0001){ref-type="fig"}).

![Effect of the treatment on the level of reduced glutathione (GSH) (**A**), the major antioxidant enzymes CAT (**B**), SOD (**C**) and the level of lipid peroxidation (MDA) (**D**) in spleen samples. \*shows the significance (p \< 0.05) in comparison to the control group. \#shows the significance (p \< 0.05) in comparison to the Cd-treated group](CEJI-39-47726-g001){#F0001}

Effect on antioxidant enzymes {#S20016}
-----------------------------

To assess the oxidative stress, activity of an important antioxidant enzyme, CAT, was assayed. After the treatment with Zn, it showed a decrease in catalase activity by 15.4% in spleen samples as compared to the control while Cd exhibited 33.6% of decrease for the same. However, its activity was found to be recovered in the combination group (Cd + Zn) by 22.8% in spleen samples as compared to Cd-treated rats ([Fig. 1B](#F0001){ref-type="fig"}).

Superoxide dismutase (SOD) is considered as one of the primary antioxidant enzymes in living systems. Treatment of rats with Zn caused a mild decrease in its activity as evidenced by group IV but group II (Cd-treated rats) showed a marked decline in its activity by 31.3% in spleen samples. Intriguingly, treatment of Zn caused a significant recovery in its activity by 27.6% in spleen samples as compared to Cd-pre-treated rats ([Fig. 1C](#F0001){ref-type="fig"})

Effect on the level of lipid peroxidation {#S20017}
-----------------------------------------

Estimation of malondialdehyde (MDA) was carried out to assess the extent of lipid peroxidation in spleen samples after the treatment. Zinc demonstrated an increase in the MDA level by 43.8% in spleen whereas Cd showed the rise by 92.8% in the samples. In the combination group (Cd + + Zn), its level decreased by 19% in spleen samples indicating the ameliorative effect of Zn on Cd-toxicity ([Fig. 1D](#F0001){ref-type="fig"}).

Zinc protected spleen and splenocytes viability against Cadmium intoxication {#S20018}
----------------------------------------------------------------------------

The relative weight of the spleen in animals from the Cd-treated group revealed that splenomegaly ([Fig. 2A](#F0002){ref-type="fig"}) was a clearly distinguishable feature compared to those from the control animals. Zinc was found to restore the relative weight of the spleen towards the normal in comparison with the control rats. To validate these observations as well as for determination of the effect of Zn on lymphocyte activities, lymphocytes from the Cd-treated rats and the other three groups were isolated and examined for cell proliferation. Viability of the lymphocytes was measured by the trypan blue exclusion test. Approximately 80% of lymphocytes of Cd-treated rats were killed in medium during 72 hours of incubation comparing to the control rats ([Fig. 2B](#F0002){ref-type="fig"}). Non-significant changes of the lymphocytes derived from Zn-treated rats comparing to the control rats.

![**A**) Relative spleen weight from different groups showing the significant higher spleen relative weight of Cd rats in comparison to the control and other groups. Zn was found to significantly restore the spleen relative weight in Cd + Zn rats. **B**) MTT assay for the cell viability percentage of splenocytes from the four different groups. Values are the mean ± SD. \*shows the significance (*p* \< 0.05) in comparison to the control group. \#shows the significance (*p* \< 0.05) in comparison to the Cd-treated group](CEJI-39-47726-g002){#F0002}

Zinc improved spleen histological architecture {#S20019}
----------------------------------------------

Light microscopic examination of sections from the spleen of Cd-treated rats showed that the white pulp was extensively diffused while mature lymphocytes in peripheral sections of the spleen were also dramatically reduced ([Fig. 3](#F0003){ref-type="fig"}) in comparison with the control rats. Spleen sections from the combination groups (Cd + Zn) however showed an obvious improvement with normal distribution of lymphocyte population and normal ratio relative to the red pulp ([Fig. 3](#F0003){ref-type="fig"}).

![Representative spleen sections stained with H&E from control (**A**) Cd + Zn (**B**), (**C**), and Zn (**D**) groups (200×)](CEJI-39-47726-g003){#F0003}

Zinc forced survival of T and B lymphocytes {#S20020}
-------------------------------------------

After MTT assay, we were interested to determine the extent to which both B and T cells were activated by Zn. Spleen sections were stained with anti-CD3 ([Fig. 4](#F0004){ref-type="fig"}) or anti-CD20 ([Fig. 5](#F0005){ref-type="fig"}) antibodies to realize T or B cells, respectively. T cells were extensively depleted in all splenic zones, especially in the PALS, in the spleen sections of the Cd-treated rats ([Fig. 4](#F0004){ref-type="fig"}) compared to the control group. Zinc was clearly found to restore these T cells quite comparable to their normal level. Furthermore, [Figure 4](#F0004){ref-type="fig"} shows that the number of B cells was significantly (p \< 0.05) reduced in both the marginal zone and lymphatic follicles of the Cd-treated rats compared to the control group. On the other hand, the number of B cells in the Cd-treated rats supplemented with Zn were significantly *(p* \< 0.05) increased in both the marginal zone and lymphatic follicles compared to the Cd-treated and the control rats ([Fig. 5](#F0005){ref-type="fig"}).

![Spleen sections stained with anti-CD3+ antibodies to realize T cells from control (A),Cd + Zn (B), Cd (C) and Zn (D) groups (200×)](CEJI-39-47726-g004){#F0004}

![Spleen sections stained with anti-CD20+ antibodies to realize B cells from control (A), Cd + Zn (B), Cd (C) and Zn (D) groups (200×)](CEJI-39-47726-g005){#F0005}

Effect of Zinc on the CXCL10 and Ccl22 chemokines, and a macrophage marker, CD68 {#S20021}
--------------------------------------------------------------------------------

After observing improvement of T and B cell homing to spleen after Zn supplementation, the present study was aimed to test lymphocyte chemo-attractant chemokines. Chemokines are low molecular weight proteins involved in trafficking the inflammatory lymphocytes during patho-genesis. Results of the RT-PCR mRNA expression of the CXCL10 and Ccl22 chemokines, and CD68 confirmed that Cd was found to significantly elevate these genes in comparison to the control samples although Zn supplementation could not restore mRNA expression of these genes to the normal levels after Cd damage ([Fig. 6](#F0006){ref-type="fig"}).

![RT-PCR mRNA expression of CD68, Ccl22 and CXCL10 (**A**) of the antigen activated lymphocytes from different groups. **B**) The relative intensity of CD68 bands. **C**) The relative intensity of Ccl22 bands. **D**) The relative intensity of CXCL10 bands. PCR products were separated and visualized by DNA agarose electrophoresis after amplification of CD68, Ccl22 and CXCL10 from splenocyte genomic DNA. Values are the mean ± SD. \*shows the significance (p \< 0.05) in comparison to the control group (Co). \#shows the significance (p \< 0.05) in comparison to the Cd-treated group](CEJI-39-47726-g006){#F0006}

Discussion {#S0022}
==========

Zinc is one of the most important minerals after iron and calcium in the living systems. Its moderate amount is essentially required in normal functioning of metabolism, defense and general well-being \[[@CIT0007]\]. The current study is an attempt to exhibit the efficacy of Zn in restoration of immunity in Cd-pre-treated rats.

As Cd exerts its toxic insults in rats by oxidative stress \[[@CIT0023]\], assessment of activity of major antioxidant enzymes (SOD, CAT, GSH) and extent of lipid peroxidation (MDA level) was carried out to confirm involvement of this stress in the present work. The results clearly demonstrate that Cd elicits its toxicity by disrupting the redox balance in rat spleen as the activity of SOD, CAT and GSH were much compromised concomitant with a highly elevated level of MDA in the Cd-treated group while the Zn-treated group showed near control levels. Interestingly, the combination of Cd with Zn exhibited normalization of the activity of antioxidant enzymes and MDA levels that tended towards the control values significantly. Thus, this part of the study entails that there is a strong involvement of oxidative stress and Cd elicited free radical(s) damage that is significantly countered by Zn.

As Zn is an important component of CuZnSOD that plays an important role in activation of the enzyme, it is quite evident here that supplementation of Zn improved its activity that might act as an initiating contributor in restoration of the normal redox status in Cd-pre-treated rats \[[@CIT0024]\]. In the same league, CAT and GSH might also assist to maintain the delicate balance of generation and quenching of damaging free radicals (superoxide anions, hydroxyl radicals). It might be the reason for a significant decrease in the MDA levels after treatment with Zn in the Cd-pre-treated group. These findings are also in agreement with earlier investigations that clearly showed that a supplementary diet of Zn in moderate amounts enhances gene expression of major antioxidant enzymes and protective proteins \[[@CIT0010]\].

A depletion of lymphocytes, both T and B, has been demonstrated by the histological and immunohistochemical staining of spleen sections from the Cd-treated group. In addition, the proliferation of lymphocytes was found to be suppressed in Cd-treated rats. On the other hand, Zn served to activate the proliferation of B and T lymphocytes in Cd-treated rats both *in vivo* and *in vitro*. Furthermore, the T and B cell homing to the spleen was clearly restored after Zn treatment.

Although CXCL10 and its receptor, CXCR3, appear to contribute to the pathogenesis of many autoimmune diseases, organ specific or systemic \[[@CIT0015]\], CXCL10 may not interfere with the pathogenesis caused by Cd contamination. Although Zn supplementation improved the histological structure of spleen and the homing of T and B cells with restoration of oxidative stability in this organ, it could not restore mRNA expression of CXCL10, Ccl22, and CD68 to the normal levels after Cd impairment of these genes. This indicates that Zn-induced improvement was not due to the suppression of these genes. It might be due to the oxidative stability and the suppression of its oxidative-related markers such as TNF-a and its receptors which play crucial roles in the pathogenesis of diseases since the prognosis of patients has improved by biologics targeting TNF-α and interleukin 6 \[[@CIT0025]\].
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